Garner Health

A spreadsheet decides who your doctor should be.

Somewhere in New York, an employee opens an app, types “knee pain,” and gets a short list. Not the closest doctors. Not the ones with the friendliest websites. The ones whose patients, statistically, got better and paid less. Then the app does something American healthcare almost never does: it offers to cover the bill.

This is Garner Health on an ordinary Tuesday. Nearly 800 employers and health systems now route their people through it - USA Today, Paylocity, Archer-Daniels-Midland, Mercy, the University of Oklahoma. Behind the tidy list of doctors sits a database of roughly 60 billion medical records covering 320 million patients, scored against more than 550 proprietary clinical metrics. The company is, as of May 2026, worth $2.74 billion.

The pitch is almost suspiciously simple. Most of healthcare is sold on access - more doctors, more locations, more telehealth. Garner sells on a different axis entirely: not more care, but better-chosen care. The whole company is a bet that those are not the same thing.

Everyone has a doctor. Almost no one knows if theirs is any good.

Here is the awkward truth the industry mostly avoids out loud: the gap between a top-performing doctor and an average one is enormous - in outcomes, in unnecessary procedures, in cost - and patients have basically no way to tell them apart. Online reviews measure parking and bedside manner. Insurance directories measure who is in-network. Neither measures whether you got better.

The result is a market where price and quality float free of each other. A more expensive doctor is not a better one. A popular practice is not a safer one. And the person paying - increasingly the patient, through ballooning deductibles - has the least information of anyone in the room.

Garner's founders looked at that and saw something almost offensive in its inefficiency: the data to fix it already existed. It was just locked inside billions of insurance claims, written in a language nobody had bothered to translate into a recommendation.

A back injury, a quant, and a hunch about incentives.

The origin story is unglamorous, which is part of why it's believable. Nick Reber had chronic back pain and could not find a doctor he trusted to fix it. The frustrating part wasn't the pain - it was the guessing. He had spent his career measuring things precisely and here was the most important decision of his year, made essentially blind.

Reber's resume reads like a setup for exactly this company. He had been co-head of Research Analytics at Bridgewater Associates, where the job is turning oceans of messy data into decisions you can stake money on. Then he helped scale Oscar Health past $2 billion in revenue, working on analytics and provider networks - close enough to the healthcare machine to see where the bodies, and the data, were buried.

In 2019 he started Garner on a two-part bet. First, that claims data, read at sufficient scale, could reliably rank doctors on outcomes. Second - the harder one - that information alone would change nothing unless you also moved the money. People don't switch doctors because a chart says to. They switch when switching is cheaper. So Garner paired the rankings with employer-funded accounts that reimburse out-of-pocket costs when you see a top provider. Carrot, not lecture.

A research lab in the back. A concierge at the front.

Garner is really two machines bolted together. One faces the data; one faces the patient. Keeping both honest is the whole trick.

Notice what's missing: Garner doesn't employ the doctors, own the clinics, or sell the insurance. It sits in the one seat nobody else wanted - the seat of the informed referee - and gets paid when its calls save everyone money.

The numbers that convinced Kaiser, Sequoia and Founders Fund.

Skeptics are right to ask whether a doctor-ranking startup is a real business or a clever dashboard. Garner's answer is its growth curve. Investors repriced the company roughly 2x in about three and a half months - the kind of move that only happens when the underlying numbers keep clearing the bar.

Realign the money with the medicine.

Strip away the funding headlines and Garner's mission is a single structural claim: American healthcare is misaligned because financial incentives point away from quality. Fix the alignment - reward good care with lower cost - and behavior changes on its own. No mandates, no scolding, no rationing.

It's a quietly radical idea precisely because it's so unromantic. Garner isn't trying to invent a new drug or a new scanner. It's trying to make the existing system spend its money on the doctors who already get better results. The innovation is the matchmaking, not the medicine.

Back to that Tuesday.

Return to the employee with knee pain and the short list on the screen. A few years ago that person would have asked a coworker, googled a name, and hoped. Today an engine that has read more medical records than any single hospital ever could hands them a doctor with a track record - and an employer willing to pay so the better choice is also the cheaper one.

That is the entire company, compressed into one tap. Not a new hospital. Not a new pill. Just the radical act of telling patients which existing doctor is good, and then making it affordable to go.

Whether Garner grows into the referee for all of American healthcare or remains an employer-benefits powerhouse, the question it forced into the open isn't going away: if we can measure which doctors are better, why have we spent so long pretending we can't? The spreadsheet, it turns out, had an opinion all along.